can i take semaglutide forever for Weight Loss: How It Works, Comparisons, and More Long-Term Ozempic Use for Weight

doi:10.2337/db13-1563 39

Bourron O, Ciangura C, Bouillot JL, Massias L, Poitou C, Oppert JM

in GLP-1

Key Background Novo Nordisk was the first major pharmaceutical company to bring a GLP-1 to market with Wegovy in 2021

Regular Follow-Ups Well monitor your progress, adjust the treatment plan as needed, and celebrate your achievements together.

NCT04847557) seeks to evaluate the effect of tirzepatide (is a dual agonist for the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors) over 52 weeks in 700 patients with heart failure with preserved ejection fraction (HFpEF) and obesity